Global study tracks MSA progression to unlock clues for future treatments

NCT ID NCT05453058

First seen Jan 11, 2026 · Last updated May 15, 2026 · Updated 19 times

Summary

This study follows 90 people with Multiple System Atrophy (MSA) in China and Europe for 12 months to understand how the disease progresses. Researchers will use regular check-ups, brain scans, and blood tests to measure changes. The goal is to gather information that could help design better treatments in the future, not to test a new drug.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MULTIPLE SYSTEM ATROPHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Beijing Hospital

    Beijing, 100730, China

  • Beijing Tiantan Hospital, Capital Medical University

    Beijing, 100050, China

  • Beijing Xuanwu Hospital, Capital Medical University

    Beijing, 100053, China

  • Huashan Hospital of Fudan University

    Shanghai, 200040, China

  • Peking Union Medical College Hospital, Chinese Academy of Medical Sciences

    Beijing, 100730, China

  • The Second Affiliated Hospital of Soochow University

    Suzhou, 215004, China

  • West China Hospital of Sichuan University

    Chengdu, 610041, China

  • Xiangya Hospital of Central South University

    Changsha, 410008, China

Conditions

Explore the condition pages connected to this study.